Chronic Obstructive Pulmonary Disease-Related Mortality in Brazil, 2000-2019: A Multiple-Cause-of-Death Study

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
Citação
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.19, n.1, p.216-225, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Chronic obstructive pulmonary disease (COPD) remains a compelling cause of morbidity and mortality; however, it is underestimated and undertreated in Brazil. Using multiple causes of death data from the Information System on Mortality, we evaluated, from 2000 to 2019, national proportional mortality; trends in mortality rates stratified by age, sex, and macro-region; and causes of death and seasonal variation, considering COPD as an underlying and associated cause of death. COPD occurred in 1,132,968 deaths, corresponding to a proportional mortality of 5.0% (5.2% and 4.7% among men and women), 67.6% as the underlying, and 32.4% as an associated cause of death. The standardized mortality rate decreased by 25.8% from 2000 to 2019, and the underlying, associated, male and female, Southeast, South, and Center-West region deaths revealed decreasing standardized mortality trends. The mean age at death increased from 73.2 (+/- 12.5) to 76.0 (+/- 12.0) years of age. Respiratory diseases were the leading underlying causes, totaling 69.8%, with COPD itself reported for 67.6% of deaths, followed by circulatory diseases (15.8%) and neoplasms (6.24%). Respiratory failure, pneumonia, septicemia, and hypertensive diseases were the major associated causes of death. Significant seasonal variations, with the highest proportional COPD mortality during winter, occurred in the southeast, south, and center-west regions. This study discloses the need and value to accurately document epidemiologic trends related to COPD in Brazil, provided its burden on mortality in older age as a significant cause of death, aiming at effective planning of mortality prevention and control.
Palavras-chave
Chronic obstructive pulmonary disease, cause of death, death certificate, mortality
Referências
  1. [Anonymous], 2019, JOINPOINT REGRESSION
  2. Bai JW, 2017, INT J CHRONIC OBSTR, V12, P3323, DOI 10.2147/COPD.S150243
  3. Bensenor IM, 2011, INT J TUBERC LUNG D, V15, P399
  4. Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2020, VIG BRAS 2019 VIG FA
  5. Campos HS., 2003, PULMAO, V12, P217
  6. Carvalho-Pinto RM, 2019, J BRAS PNEUMOL, V45, DOI 10.1590/1806-3713/e20180355
  7. Chakraborti A, 2019, CHEST, V156, p1164A, DOI 10.1016/j.chest.2019.08.1060
  8. Cheng Y, 2014, CHINESE MED J-PEKING, V127, P1619, DOI 10.3760/cma.j.issn.0366-6999.20132432
  9. Correa PRL., 2019, REV BRAS EPIDEMIOL, V22
  10. Cruz MM, 2020, CIENC SAUDE COLETIVA, V25, P4547, DOI 10.1590/1413-812320202511.00222019
  11. de la Iglesia Martinez F, 2000, Arch Bronconeumol, V36, P84
  12. Fernandez-Garcia A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051117
  13. Fuhrman C, 2006, THORAX, V61, P930, DOI 10.1136/thx.2006.061267
  14. Fuhrman C, 2010, REV MAL RESPIR, V27, P160, DOI 10.1016/j.rmr.2009.08.003
  15. Goncalves-Macedo L, 2019, J BRAS PNEUMOL, V45, DOI 10.1590/1806-3713/e20180402
  16. Graudenz GS, 2014, REV ASSOC MED BRAS, V60, P255, DOI 10.1590/1806-9282.60.03.015
  17. Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403
  18. Li XC, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m234
  19. Lindberg A, 2021, RESP MED, V186, DOI 10.1016/j.rmed.2021.106518
  20. Lopez, 2001, AGE STANDARDIZATION, V31, P10
  21. Lortet-Tieulent J, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01791-2019
  22. Mannino DM, 1997, AM J RESP CRIT CARE, V156, P814, DOI 10.1164/ajrccm.156.3.9702026
  23. Marcon A, 2016, COPD, V13, P35, DOI 10.3109/15412555.2015.1043427
  24. Menezes Ana Maria Baptista, 2005, Cad. Saúde Pública, V21, P1565, DOI 10.1590/S0102-311X2005000500030
  25. Meyer PA, 2002, CHEST, V122, P2003, DOI 10.1378/chest.122.6.2003
  26. Obi JI, 2018, AM J RESP CRIT CARE, V197
  27. Obi J, 2018, COPD, V15, P200, DOI 10.1080/15412555.2018.1454897
  28. Patel AR, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4985
  29. Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X
  30. Santo AH., 2019, 4 INT M MULT CAUS DE
  31. Santo AH, 1988, THESIS U SAO PAULO
  32. Santo AH., 1999, REV BRAS EPIDEMIOL, V2, P90, DOI [10.1590/S1415-790X1999000100009, DOI 10.1590/S1415-790X1999000100009]
  33. Santo AH., 2022, REASE, V8, P1620, DOI [10.51891/rease.v8i1.4008, DOI 10.51891/REASE.V8I1.4008]
  34. Santo Augusto Hasiak, 1995, Boletin de la Oficina Sanitaria Panamericana, V119, P319
  35. Sasieta Tello HC., 2014, AM J RESP CRIT CARE, V189
  36. Silva D, 2020, VALUE HEALTH, V23, pS727
  37. World Health Organization, 1993, INT STAT CLASS DIS R, V1
  38. World Health Organization, 1993, INSTRUCTION MANUAL, V2